Literature DB >> 9037766

Characterization of group B streptococcal invasion in HEp-2 epithelial cells.

P Valentin-Weigand1, H Jungnitz, A Zock, M Rohde, G S Chhatwal.   

Abstract

The invasion of group B streptococci (GBS) in HEp-2 epithelial cells was analyzed by electron microscopy and a quantitative antibiotic survival assay. Invasion of GBS involved intimate attachment of streptococcal chains, engulfment of the adherent bacteria by cellular protrusions, entry of the bacteria in a 'polar' fashion and formation of membrane-bound vacuoles in which most of the intracellular streptococci resided. At later stages of infection bacteria were also found free in the cytoplasm. Efficient uptake of streptococci by HEp-2 cells occurred within 20 min and live intracellular bacteria were detectable up to 48 h post-infection. Invasion of GBS required activation of the eukaryotic actin microfilament system involving, at least partially, protein kinase signal transduction pathways. Invasion was inhibited in a dose-dependent manner by decreasing extracellular Ca2+ levels as well as by substances known to interfere with eukaryotic calcium regulatory systems. These results suggest that GBS invade HEp-2 cells by triggering calcium-dependent phagocytosis-like internalization mechanisms and persist intracellularly both in vacuoles and free in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037766     DOI: 10.1111/j.1574-6968.1997.tb10222.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

Review 1.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

Review 2.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

3.  Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus.

Authors:  D J Reinscheid; B Gottschalk; A Schubert; B J Eikmanns; G S Chhatwal
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

Review 4.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Cytolysin-dependent evasion of lysosomal killing.

Authors:  Anders Håkansson; Colette Cywes Bentley; Elizabeth A Shakhnovic; Michael R Wessels
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

Review 6.  Group B Streptococcus: global incidence and vaccine development.

Authors:  Atul Kumar Johri; Lawrence C Paoletti; Philippe Glaser; Meenakshi Dua; Puja Kumari Sharma; Guido Grandi; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2006-11-06       Impact factor: 60.633

7.  Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro.

Authors:  S B Winram; M Jonas; E Chi; C E Rubens
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

8.  Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine.

Authors:  Lara Macchioni; Katia Fettucciari; Magdalena Davidescu; Rita Vitale; Pamela Ponsini; Emanuela Rosati; Angela Corcelli; Pierfrancesco Marconi; Lanfranco Corazzi
Journal:  J Bioenerg Biomembr       Date:  2013-08-25       Impact factor: 2.945

9.  A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains.

Authors:  Andrzej Pawlowski; Jonas Lannergård; Majela Gonzalez-Miro; Duojia Cao; Sara Larsson; Jenny J Persson; Geoff Kitson; Michael Darsley; Ane Lilleøre Rom; Morten Hedegaard; Per B Fischer; Bengt Johansson-Lindbom
Journal:  Cell Rep Med       Date:  2022-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.